James Patrick Buteau

机构：The University of Melbourne, Peter MacCallum Cancer Centre · ORCID：0000-0001-5693-2913

发表论文 65 篇 · 总被引 1980 次 · h-index 20

代表论文

First-in-human results of terbium-161 [161Tb]Tb-PSMA-I&T dual beta–Auger radioligand therapy in patients with metastatic castration-resistant prostate cancer (VIOLET): a single-centre, single-arm, phase 1/2 study (2025 · The Lancet Oncology · 被引 57)
Lutetium-177–PSMA-617 or cabazitaxel in metastatic prostate cancer: circulating tumor DNA analysis of the randomized phase 2 TheraP trial (2025 · Nature Medicine · 被引 39)
Beyond Prostate Imaging Reporting and Data System: Combining Magnetic Resonance Imaging Prostate Imaging Reporting and Data System and Prostate-Specific Membrane Antigen–Positron Emission Tomography/Computed Tomography PRIMARY Score in a Composite (P) Score for More Accurate Diagnosis of Clinically Significant Prostate Cancer (2024 · The Journal of Urology · 被引 33)
Clinical Trial Protocol for VIOLET: A Single-Center, Phase I/II Trial Evaluation of Radioligand Treatment in Patients with Metastatic Castration-Resistant Prostate Cancer with [161Tb]Tb-PSMA-I&T (2024 · Journal of Nuclear Medicine · 被引 32)
Therapy-Related Myeloid Neoplasms After [ 177 Lu]Lu-PSMA Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: A Case Series (2025 · Journal of Nuclear Medicine · 被引 21)
Lutetium-177 [177Lu]Lu-PSMA-I&T plus radium-223 in patients with metastatic castration-resistant prostate cancer (AlphaBet): an interim analysis of the investigator-initiated, single-centre, single-arm, phase 1/2 trial (2025 · The Lancet Oncology · 被引 19)